Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Harvard Business School
Federal Trade Commission
McKinsey
Covington
AstraZeneca
Chubb
Baxter

Generated: December 14, 2018

DrugPatentWatch Database Preview

Sodium iodide i-131 - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium iodide i-131 and what is the scope of sodium iodide i-131 freedom to operate?

Sodium iodide i-131 is the generic ingredient in three branded drugs marketed by Bracco, CIS, Jubilant Draximage, and Mallinkrodt Nuclear, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and fifty-four drug master file entries for sodium iodide i-131. One supplier is listed for this compound.

Summary for sodium iodide i-131
Pharmacology for sodium iodide i-131

US Patents and Regulatory Information for sodium iodide i-131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Draximage HICON sodium iodide i-131 SOLUTION;ORAL 021305-005 Apr 4, 2006 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jubilant Draximage HICON sodium iodide i-131 SOLUTION;ORAL 021305-007 Dec 5, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cis SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 017316-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cis SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 017316-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016517-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 SOLUTION;ORAL 016515-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016515-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Harvard Business School
Federal Trade Commission
McKinsey
Covington
AstraZeneca
Chubb
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.